We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 661

International Trade Compliance Update - September 2016
  • Baker & McKenzie
  • Australia, Canada, European Union, United Kingdom, USA
  • September 7 2016

On 19 August 2016, the Russian Federation notified the WTO that it intends to initiate negotiations pursuant to Paragraph 1143 of the Working Party


PCK StartIP Series: 2 - Patent Grace Periods; A Way for a Lean Startup to Defer Patent Filing Costs
  • PCK Perry + Currier Inc Currier + Kao LLP
  • Canada, USA
  • August 24 2016

Provisional patent applications are the traditional way that a lean startup can obtain some preliminary patent protection at reasonable cost while


Reflection on Pharmaceutical Patent Litigation in Canada: An Opportunity for Change
  • Fasken Martineau DuMoulin LLP
  • Canada, USA
  • June 29 2016

Pharmaceutical products provide customers with treatments and cures for various Illnesses and increase life quality and expectancy. It is critical


Patenting Polymorphs of Crystals Internationally
  • Bereskin & Parr LLP
  • Canada, European Union, Japan, USA
  • June 27 2016

Polymorphs are patentable subject matter in Canada and the U.S. Our prior article discussed some best practices to differentiate a new polymorph from


Ontario Superior Court again refuses to strike claims pursuant to the Statute of Monopolies and the Trade-marks Act
  • Borden Ladner Gervais LLP
  • Canada, USA
  • June 15 2016

The defendant corporations sought to strike Apotex's claims to: Treble damages pursuant to s 4 of An Act concerning Monopolies and Dispensation with


Application for prohibition is struck on motion after the Court construes the patent and finds no infringement
  • Borden Ladner Gervais LLP
  • Canada, USA
  • June 15 2016

Celltrion has successfully struck a prohibition application brought by Janssen after Celltrion sought to add indications to its already approved drug


Looking into the Crystal Ball - Protecting Polymporphs to Lengthen the Drug Patent Life Cycle
  • Bereskin & Parr LLP
  • Canada, USA
  • June 7 2016

Innovative pharmaceutical companies are increasingly attempting to patent improved forms of their original drug compound. Crystalline forms of a drug


Bennett Jones Spring 2016 Economic Outlook
  • Bennett Jones LLP
  • Canada, European Union, OECD, United Kingdom, USA
  • June 7 2016

This Spring Outlook has three sections. The first section sets out our view of the economic outlook commencing with a very short summary of recent


Life Sciences Legal Trends in Canada
  • Borden Ladner Gervais LLP
  • Canada, European Union, United Kingdom, USA
  • June 6 2016

The doctrine of “sound prediction” was ushered into Canadian law as a means to protect useful inventions. A review of the case law, however, reveals


Trial opinion issues in Suboxone ANDA case
  • Morris James LLP
  • Canada, USA
  • June 3 2016

Andrews, J. Trial opinion finding the asserted claims in one patent invalid and certain products would infringe if valid; the asserted claims of a